Mealey's (November 19, 2018, 1:40 PM EST) -- NEW YORK — A medical device maker and its CEO will pay $54.5 million to settle claims that they misrepresented the safety and commercial viability of the company’s heart pump product in violation of federal securities laws, according to documents filed Nov. 13 in New York federal court (In re HeartWare International Inc. Securities Litigation, No. 16-0520, S.D. N.Y.)....